Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

April 01, 2013; Volume 41,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abraham, Trent L.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  2. Alberts, Jeffrey J.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  3. Amano, Nobuyuki

    1. You have access
      Retrospective Analysis of P-Glycoprotein–Mediated Drug-Drug Interactions at the Blood-Brain Barrier in Humans
      Hiroshi Sugimoto, Hideki Hirabayashi, Nobuyuki Amano and Toshiya Moriwaki
      Drug Metabolism and Disposition April 2013, 41 (4) 683-688; DOI: https://doi.org/10.1124/dmd.112.049577
  4. Anderson, Shelby

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  5. Arico-Muendel, Christopher C.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  6. Asahi, Satoru

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650

B

  1. Balimane, Praveen V.

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
  2. Bankstahl, Jens P.

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  3. Bankstahl, Marion

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  4. Barbuch, Robert J.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  5. Batheja, Ameesha

    1. You have access
      Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes
      Shannon Dallas, Souvik Chattopadhyay, Carlo Sensenhauser, Ameesha Batheja, Monica Singer and Jose Silva
      Drug Metabolism and Disposition April 2013, 41 (4) 689-693; DOI: https://doi.org/10.1124/dmd.112.048884
  6. Belanger, Bruce

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  7. Benjamin, Dennis

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  8. Bergman, Peter

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136
  9. Bird, James

    1. You have access
      Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor
      Pär Nordell, Petter Svanberg, James Bird and Ken Grime
      Drug Metabolism and Disposition April 2013, 41 (4) 836-843; DOI: https://doi.org/10.1124/dmd.112.050377
  10. Björkhem-Bergman, Linda

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136
  11. Blanchette, Heather S.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  12. Bommareddy, Ajay

    1. You have access
      Organic Anion Transporter 3 Interacts Selectively with Lipophilic β-Lactam Antibiotics
      Aaron T. Wolman, Michael R. Gionfriddo, Gregory A. Heindel, Paran Mukhija, Sarah Witkowski, Ajay Bommareddy and Adam L. VanWert
      Drug Metabolism and Disposition April 2013, 41 (4) 791-800; DOI: https://doi.org/10.1124/dmd.112.049569
  13. Boysen, Gunnar

    1. You have access
      Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
      Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser and Susan Kadlubar
      Drug Metabolism and Disposition April 2013, 41 (4) 870-877; DOI: https://doi.org/10.1124/dmd.112.048157
  14. Bradbury, J. Alyce

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  15. Buckley, David B.

    1. You have access
      Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
      Faraz Kazmi, Tiffini Hensley, Chad Pope, Ryan S. Funk, Greg J. Loewen, David B. Buckley and Andrew Parkinson
      Drug Metabolism and Disposition April 2013, 41 (4) 897-905; DOI: https://doi.org/10.1124/dmd.112.050054

C

  1. Caiazzo, Teresa M.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  2. Cass, Carol E.

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  3. Cassidy, Kenneth C.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  4. Centrella, Paolo A.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  5. Cha, Eun-Young

    1. You have access
      Identification and Characterization of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor in Liver Samples of Koreans and Caucasians
      Eun-Jung Choi, Yin-Jin Jang, Eun-Young Cha, Jae-Gook Shin and Sang Seop Lee
      Drug Metabolism and Disposition April 2013, 41 (4) 888-896; DOI: https://doi.org/10.1124/dmd.112.049791
  6. Chattopadhyay, Souvik

    1. You have access
      Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes
      Shannon Dallas, Souvik Chattopadhyay, Carlo Sensenhauser, Ameesha Batheja, Monica Singer and Jose Silva
      Drug Metabolism and Disposition April 2013, 41 (4) 689-693; DOI: https://doi.org/10.1124/dmd.112.048884
  7. Cheng, Jennifer

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  8. Choi, Eun-Jung

    1. You have access
      Identification and Characterization of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor in Liver Samples of Koreans and Caucasians
      Eun-Jung Choi, Yin-Jin Jang, Eun-Young Cha, Jae-Gook Shin and Sang Seop Lee
      Drug Metabolism and Disposition April 2013, 41 (4) 888-896; DOI: https://doi.org/10.1124/dmd.112.049791
  9. Chow, Kay H.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  10. Clayton, Natasha P.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  11. Cline, Cynthia

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  12. Crafford, Amanda

    1. You have access
      Methadone N-Demethylation by the Common CYP2B6 Allelic Variant CYP2B6.6
      Sarah Gadel, Amanda Crafford, Karen Regina and Evan D. Kharasch
      Drug Metabolism and Disposition April 2013, 41 (4) 709-713; DOI: https://doi.org/10.1124/dmd.112.050625
  13. Cui, Julia Y.

    1. You have access
      RNA-Sequencing Quantification of Hepatic Ontogeny and Tissue Distribution of mRNAs of Phase II Enzymes in Mice
      Hong Lu, Sumedha Gunewardena, Julia Y. Cui, Byunggil Yoo, Xiao-bo Zhong and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2013, 41 (4) 844-857; DOI: https://doi.org/10.1124/dmd.112.050211

D

  1. Dallas, Shannon

    1. You have access
      Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes
      Shannon Dallas, Souvik Chattopadhyay, Carlo Sensenhauser, Ameesha Batheja, Monica Singer and Jose Silva
      Drug Metabolism and Disposition April 2013, 41 (4) 689-693; DOI: https://doi.org/10.1124/dmd.112.048884
  2. Damaraju, Vijaya L.

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  3. DeLorey, Jennifer

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  4. Dhakal, Ishwori B.

    1. You have access
      Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
      Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser and Susan Kadlubar
      Drug Metabolism and Disposition April 2013, 41 (4) 870-877; DOI: https://doi.org/10.1124/dmd.112.048157
  5. Diczfalusy, Ulf

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136
  6. Doyle, Elisabeth G.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355

E

  1. Edavana, Vineetha Koroth

    1. You have access
      Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
      Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser and Susan Kadlubar
      Drug Metabolism and Disposition April 2013, 41 (4) 870-877; DOI: https://doi.org/10.1124/dmd.112.048157
  2. Edin, Matthew L.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  3. Ekins, Sean

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  4. Ekström, Lena

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136
  5. Eliasson, Erik

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136
  6. Erker, Thomas

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148

F

  1. Falardeau, Sarah-Ann

    1. You have access
      The Relative Protein Abundance of UGT1A Alternative Splice Variants as a Key Determinant of Glucuronidation Activity In Vitro
      Mélanie Rouleau, Joannie Roberge, Sarah-Ann Falardeau, Lyne Villeneuve and Chantal Guillemette
      Drug Metabolism and Disposition April 2013, 41 (4) 694-697; DOI: https://doi.org/10.1124/dmd.112.050468
  2. Fatima, Soghra

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  3. Fedrowitz, Maren

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  4. Fong, Kei-Lai

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033
  5. Frost, Charles E.

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
    2. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
  6. Fujimori, Ko

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  7. Funk, Ryan S.

    1. You have access
      Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
      Faraz Kazmi, Tiffini Hensley, Chad Pope, Ryan S. Funk, Greg J. Loewen, David B. Buckley and Andrew Parkinson
      Drug Metabolism and Disposition April 2013, 41 (4) 897-905; DOI: https://doi.org/10.1124/dmd.112.050054
  8. Furr, Nathan A.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488

G

  1. Gadel, Sarah

    1. You have access
      Methadone N-Demethylation by the Common CYP2B6 Allelic Variant CYP2B6.6
      Sarah Gadel, Amanda Crafford, Karen Regina and Evan D. Kharasch
      Drug Metabolism and Disposition April 2013, 41 (4) 709-713; DOI: https://doi.org/10.1124/dmd.112.050625
  2. Galetin, Aleksandra

    1. You have access
      Application of a Physiologically Based Pharmacokinetic Model to Assess Propofol Hepatic and Renal Glucuronidation in Isolation: Utility of In Vitro and In Vivo Data
      Katherine L. Gill, Michael Gertz, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition April 2013, 41 (4) 744-753; DOI: https://doi.org/10.1124/dmd.112.050294
  3. Gan, Jinping

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
  4. Gati, Wendy P.

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  5. Gertz, Michael

    1. You have access
      Application of a Physiologically Based Pharmacokinetic Model to Assess Propofol Hepatic and Renal Glucuronidation in Isolation: Utility of In Vitro and In Vivo Data
      Katherine L. Gill, Michael Gertz, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition April 2013, 41 (4) 744-753; DOI: https://doi.org/10.1124/dmd.112.050294
  6. Gill, Katherine L.

    1. You have access
      Application of a Physiologically Based Pharmacokinetic Model to Assess Propofol Hepatic and Renal Glucuronidation in Isolation: Utility of In Vitro and In Vivo Data
      Katherine L. Gill, Michael Gertz, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition April 2013, 41 (4) 744-753; DOI: https://doi.org/10.1124/dmd.112.050294
  7. Gionfriddo, Michael R.

    1. You have access
      Organic Anion Transporter 3 Interacts Selectively with Lipophilic β-Lactam Antibiotics
      Aaron T. Wolman, Michael R. Gionfriddo, Gregory A. Heindel, Paran Mukhija, Sarah Witkowski, Ajay Bommareddy and Adam L. VanWert
      Drug Metabolism and Disposition April 2013, 41 (4) 791-800; DOI: https://doi.org/10.1124/dmd.112.049569
  8. Goosen, Theunis C.

    1. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
  9. Gradhand, Ulrike

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  10. Graves, Joan P.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  11. Griffin, Sarah T.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  12. Grime, Ken

    1. You have access
      Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor
      Pär Nordell, Petter Svanberg, James Bird and Ken Grime
      Drug Metabolism and Disposition April 2013, 41 (4) 836-843; DOI: https://doi.org/10.1124/dmd.112.050377
  13. Gruzdev, Artiom

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  14. Guillemette, Chantal

    1. You have access
      The Relative Protein Abundance of UGT1A Alternative Splice Variants as a Key Determinant of Glucuronidation Activity In Vitro
      Mélanie Rouleau, Joannie Roberge, Sarah-Ann Falardeau, Lyne Villeneuve and Chantal Guillemette
      Drug Metabolism and Disposition April 2013, 41 (4) 694-697; DOI: https://doi.org/10.1124/dmd.112.050468
  15. Gunewardena, Sumedha

    1. You have access
      RNA-Sequencing Quantification of Hepatic Ontogeny and Tissue Distribution of mRNAs of Phase II Enzymes in Mice
      Hong Lu, Sumedha Gunewardena, Julia Y. Cui, Byunggil Yoo, Xiao-bo Zhong and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2013, 41 (4) 844-857; DOI: https://doi.org/10.1124/dmd.112.050211

H

  1. Hall, Adrian

    1. You have access
      Reversible Inhibition of Human Carboxylesterases by Acyl Glucuronides
      Natalie R. Inoue, Adrian Hall, W. George Lai and Eric T. Williams
      Drug Metabolism and Disposition April 2013, 41 (4) 698-703; DOI: https://doi.org/10.1124/dmd.112.050252
  2. Han, Yong-Hae

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
  3. He, Fang

    1. You have access
      Identification of the Active Components in Shenmai Injection that Differentially Affect Cyp3a4-Mediated 1′-Hydroxylation and 4-Hydroxylation of Midazolam
      Caiwen Zeng, Fang He, Chunhua Xia, Hong Zhang and Yuqing Xiong
      Drug Metabolism and Disposition April 2013, 41 (4) 785-790; DOI: https://doi.org/10.1124/dmd.112.048025
  4. He, Kan

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
    2. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
  5. Heindel, Gregory A.

    1. You have access
      Organic Anion Transporter 3 Interacts Selectively with Lipophilic β-Lactam Antibiotics
      Aaron T. Wolman, Michael R. Gionfriddo, Gregory A. Heindel, Paran Mukhija, Sarah Witkowski, Ajay Bommareddy and Adam L. VanWert
      Drug Metabolism and Disposition April 2013, 41 (4) 791-800; DOI: https://doi.org/10.1124/dmd.112.049569
  6. Hensley, Tiffini

    1. You have access
      Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
      Faraz Kazmi, Tiffini Hensley, Chad Pope, Ryan S. Funk, Greg J. Loewen, David B. Buckley and Andrew Parkinson
      Drug Metabolism and Disposition April 2013, 41 (4) 897-905; DOI: https://doi.org/10.1124/dmd.112.050054
  7. Herbst, John J.

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
  8. Hill, Susan

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  9. Hirabayashi, Hideki

    1. You have access
      Retrospective Analysis of P-Glycoprotein–Mediated Drug-Drug Interactions at the Blood-Brain Barrier in Humans
      Hiroshi Sugimoto, Hideki Hirabayashi, Nobuyuki Amano and Toshiya Moriwaki
      Drug Metabolism and Disposition April 2013, 41 (4) 683-688; DOI: https://doi.org/10.1124/dmd.112.049577
  10. Hollenberg, Paul F.

    1. You have access
      The Inactivation of Human CYP2E1 by Phenethyl Isothiocyanate, a Naturally Occurring Chemopreventive Agent, and Its Oxidative Bioactivation
      Yasushi Yoshigae, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition April 2013, 41 (4) 858-869; DOI: https://doi.org/10.1124/dmd.112.050609
  11. Honda, Tomohiro

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591
  12. Houston, J. Brian

    1. You have access
      Application of a Physiologically Based Pharmacokinetic Model to Assess Propofol Hepatic and Renal Glucuronidation in Isolation: Utility of In Vitro and In Vivo Data
      Katherine L. Gill, Michael Gertz, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition April 2013, 41 (4) 744-753; DOI: https://doi.org/10.1124/dmd.112.050294
  13. Hu, Haitao

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  14. Humphreys, W. Griffith

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
    2. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575

I

  1. Inoue, Natalie R.

    1. You have access
      Reversible Inhibition of Human Carboxylesterases by Acyl Glucuronides
      Natalie R. Inoue, Adrian Hall, W. George Lai and Eric T. Williams
      Drug Metabolism and Disposition April 2013, 41 (4) 698-703; DOI: https://doi.org/10.1124/dmd.112.050252
  2. Isoherranen, Nina

    1. You have access
      A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
      Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan, Nina Isoherranen and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2013, 41 (4) 801-813; DOI: https://doi.org/10.1124/dmd.112.050161
  3. Izumi, Takashi

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591

J

  1. Jackson, Kimberley A.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  2. Jang, Yin-Jin

    1. You have access
      Identification and Characterization of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor in Liver Samples of Koreans and Caucasians
      Eun-Jung Choi, Yin-Jin Jang, Eun-Young Cha, Jae-Gook Shin and Sang Seop Lee
      Drug Metabolism and Disposition April 2013, 41 (4) 888-896; DOI: https://doi.org/10.1124/dmd.112.049791

K

  1. Kadlubar, Susan

    1. You have access
      Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
      Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser and Susan Kadlubar
      Drug Metabolism and Disposition April 2013, 41 (4) 870-877; DOI: https://doi.org/10.1124/dmd.112.048157
  2. Kakuta, Masayo

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591
  3. Kaneno-Urasaki, Yoko

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591
  4. Karpinski, Edward

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  5. Kazmi, Faraz

    1. You have access
      Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
      Faraz Kazmi, Tiffini Hensley, Chad Pope, Ryan S. Funk, Greg J. Loewen, David B. Buckley and Andrew Parkinson
      Drug Metabolism and Disposition April 2013, 41 (4) 897-905; DOI: https://doi.org/10.1124/dmd.112.050054
  6. Ke, Alice Ban

    1. You have access
      A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
      Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan, Nina Isoherranen and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2013, 41 (4) 801-813; DOI: https://doi.org/10.1124/dmd.112.050161
  7. Kent, Ute M.

    1. You have access
      The Inactivation of Human CYP2E1 by Phenethyl Isothiocyanate, a Naturally Occurring Chemopreventive Agent, and Its Oxidative Bioactivation
      Yasushi Yoshigae, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition April 2013, 41 (4) 858-869; DOI: https://doi.org/10.1124/dmd.112.050609
  8. Kharasch, Evan D.

    1. You have access
      Methadone N-Demethylation by the Common CYP2B6 Allelic Variant CYP2B6.6
      Sarah Gadel, Amanda Crafford, Karen Regina and Evan D. Kharasch
      Drug Metabolism and Disposition April 2013, 41 (4) 709-713; DOI: https://doi.org/10.1124/dmd.112.050625
  9. Klaassen, Curtis D.

    1. You have access
      RNA-Sequencing Quantification of Hepatic Ontogeny and Tissue Distribution of mRNAs of Phase II Enzymes in Mice
      Hong Lu, Sumedha Gunewardena, Julia Y. Cui, Byunggil Yoo, Xiao-bo Zhong and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2013, 41 (4) 844-857; DOI: https://doi.org/10.1124/dmd.112.050211
  10. Koga, Tetsufumi

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591
  11. Kogame, Akifumi

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  12. Kolb, Janet

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
  13. Kondo, Takahiro

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  14. Kulanthaivel, Palaniappan

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  15. Kuntner, Claudia

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148

L

  1. Labenski, Matthew T.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  2. Lai, W. George

    1. You have access
      Reversible Inhibition of Human Carboxylesterases by Acyl Glucuronides
      Natalie R. Inoue, Adrian Hall, W. George Lai and Eric T. Williams
      Drug Metabolism and Disposition April 2013, 41 (4) 698-703; DOI: https://doi.org/10.1124/dmd.112.050252
  3. Langer, Oliver

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  4. Lee, Sang Seop

    1. You have access
      Identification and Characterization of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor in Liver Samples of Koreans and Caucasians
      Eun-Jung Choi, Yin-Jin Jang, Eun-Young Cha, Jae-Gook Shin and Sang Seop Lee
      Drug Metabolism and Disposition April 2013, 41 (4) 888-896; DOI: https://doi.org/10.1124/dmd.112.049791
  5. Lepist, Eve-Irene

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  6. Leung, Kwan H.

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  7. Lih, Fred B.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  8. Lindh, Jonatan D.

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136
  9. Loewen, Greg J.

    1. You have access
      Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
      Faraz Kazmi, Tiffini Hensley, Chad Pope, Ryan S. Funk, Greg J. Loewen, David B. Buckley and Andrew Parkinson
      Drug Metabolism and Disposition April 2013, 41 (4) 897-905; DOI: https://doi.org/10.1124/dmd.112.050054
  10. Löscher, Wolfgang

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  11. Lu, Hong

    1. You have access
      RNA-Sequencing Quantification of Hepatic Ontogeny and Tissue Distribution of mRNAs of Phase II Enzymes in Mice
      Hong Lu, Sumedha Gunewardena, Julia Y. Cui, Byunggil Yoo, Xiao-bo Zhong and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2013, 41 (4) 844-857; DOI: https://doi.org/10.1124/dmd.112.050211

M

  1. Masinde, Tiwanda A.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  2. Matsunaga, Norikazu

    1. You have access
      Evaluation of Hepatic Disposition of Paroxetine Using Sandwich-Cultured Rat and Human Hepatocytes
      Norikazu Matsunaga, Ken-ichi Nunoya, Masahiro Okada, Mikio Ogawa and Ikumi Tamai
      Drug Metabolism and Disposition April 2013, 41 (4) 735-743; DOI: https://doi.org/10.1124/dmd.112.049817
  3. McCann, Denis J.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  4. Miyamoto, Maki

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  5. Morgan, Barry A.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  6. Moriwaki, Toshiya

    1. You have access
      Retrospective Analysis of P-Glycoprotein–Mediated Drug-Drug Interactions at the Blood-Brain Barrier in Humans
      Hiroshi Sugimoto, Hideki Hirabayashi, Nobuyuki Amano and Toshiya Moriwaki
      Drug Metabolism and Disposition April 2013, 41 (4) 683-688; DOI: https://doi.org/10.1124/dmd.112.049577
  7. Moriya, Yuu

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033
  8. Morrison, James P.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  9. Mukhija, Paran

    1. You have access
      Organic Anion Transporter 3 Interacts Selectively with Lipophilic β-Lactam Antibiotics
      Aaron T. Wolman, Michael R. Gionfriddo, Gregory A. Heindel, Paran Mukhija, Sarah Witkowski, Ajay Bommareddy and Adam L. VanWert
      Drug Metabolism and Disposition April 2013, 41 (4) 791-800; DOI: https://doi.org/10.1124/dmd.112.049569
  10. Müller, Markus

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  11. Murai, Takahiro

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591

N

  1. Nallani, Srikanth C.

    1. You have access
      A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
      Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan, Nina Isoherranen and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2013, 41 (4) 801-813; DOI: https://doi.org/10.1124/dmd.112.050161
  2. Namba, Eiko

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591
  3. Nasu, Hatsumi

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591
  4. Nordell, Pär

    1. You have access
      Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor
      Pär Nordell, Petter Svanberg, James Bird and Ken Grime
      Drug Metabolism and Disposition April 2013, 41 (4) 836-843; DOI: https://doi.org/10.1124/dmd.112.050377
  5. Norlin, Anna-Carin

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136
  6. Nunoya, Ken-ichi

    1. You have access
      Evaluation of Hepatic Disposition of Paroxetine Using Sandwich-Cultured Rat and Human Hepatocytes
      Norikazu Matsunaga, Ken-ichi Nunoya, Masahiro Okada, Mikio Ogawa and Ikumi Tamai
      Drug Metabolism and Disposition April 2013, 41 (4) 735-743; DOI: https://doi.org/10.1124/dmd.112.049817
  7. Nylén, Hanna

    1. You have access
      Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
      Linda Björkhem-Bergman, Hanna Nylén, Anna-Carin Norlin, Jonatan D. Lindh, Lena Ekström, Erik Eliasson, Peter Bergman and Ulf Diczfalusy
      Drug Metabolism and Disposition April 2013, 41 (4) 704-708; DOI: https://doi.org/10.1124/dmd.113.051136

O

  1. O’Donovan, Gary

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  2. Ogawa, Mikio

    1. You have access
      Evaluation of Hepatic Disposition of Paroxetine Using Sandwich-Cultured Rat and Human Hepatocytes
      Norikazu Matsunaga, Ken-ichi Nunoya, Masahiro Okada, Mikio Ogawa and Ikumi Tamai
      Drug Metabolism and Disposition April 2013, 41 (4) 735-743; DOI: https://doi.org/10.1124/dmd.112.049817
  3. Okada, Masahiro

    1. You have access
      Evaluation of Hepatic Disposition of Paroxetine Using Sandwich-Cultured Rat and Human Hepatocytes
      Norikazu Matsunaga, Ken-ichi Nunoya, Masahiro Okada, Mikio Ogawa and Ikumi Tamai
      Drug Metabolism and Disposition April 2013, 41 (4) 735-743; DOI: https://doi.org/10.1124/dmd.112.049817
  4. Okuno, Akira

    1. You have access
      Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
      Tomohiro Honda, Yoko Kaneno-Urasaki, Takahiro Murai, Masayo Kakuta, Hatsumi Nasu, Eiko Namba, Tetsufumi Koga, Akira Okuno and Takashi Izumi
      Drug Metabolism and Disposition April 2013, 41 (4) 878-887; DOI: https://doi.org/10.1124/dmd.112.050591
  5. Onciu, Mihaela

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344

P

  1. Parkinson, Andrew

    1. You have access
      Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
      Faraz Kazmi, Tiffini Hensley, Chad Pope, Ryan S. Funk, Greg J. Loewen, David B. Buckley and Andrew Parkinson
      Drug Metabolism and Disposition April 2013, 41 (4) 897-905; DOI: https://doi.org/10.1124/dmd.112.050054
  2. Penney, Rosalind

    1. You have access
      Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
      Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser and Susan Kadlubar
      Drug Metabolism and Disposition April 2013, 41 (4) 870-877; DOI: https://doi.org/10.1124/dmd.112.048157
  3. Pope, Chad

    1. You have access
      Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
      Faraz Kazmi, Tiffini Hensley, Chad Pope, Ryan S. Funk, Greg J. Loewen, David B. Buckley and Andrew Parkinson
      Drug Metabolism and Disposition April 2013, 41 (4) 897-905; DOI: https://doi.org/10.1124/dmd.112.050054
  4. Prakash, Shimoga

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  5. Prasad, Kavirayani

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355

Q

  1. Qu, Wei

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429

R

  1. Regina, Karen

    1. You have access
      Methadone N-Demethylation by the Common CYP2B6 Allelic Variant CYP2B6.6
      Sarah Gadel, Amanda Crafford, Karen Regina and Evan D. Kharasch
      Drug Metabolism and Disposition April 2013, 41 (4) 709-713; DOI: https://doi.org/10.1124/dmd.112.050625
  2. Roberge, Joannie

    1. You have access
      The Relative Protein Abundance of UGT1A Alternative Splice Variants as a Key Determinant of Glucuronidation Activity In Vitro
      Mélanie Rouleau, Joannie Roberge, Sarah-Ann Falardeau, Lyne Villeneuve and Chantal Guillemette
      Drug Metabolism and Disposition April 2013, 41 (4) 694-697; DOI: https://doi.org/10.1124/dmd.112.050468
  3. Rodrigues, A. David

    1. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
  4. Römermann, Kerstin

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  5. Rostami-Hodjegan, Amin

    1. You have access
      A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
      Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan, Nina Isoherranen and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2013, 41 (4) 801-813; DOI: https://doi.org/10.1124/dmd.112.050161
  6. Rouleau, Mélanie

    1. You have access
      The Relative Protein Abundance of UGT1A Alternative Splice Variants as a Key Determinant of Glucuronidation Activity In Vitro
      Mélanie Rouleau, Joannie Roberge, Sarah-Ann Falardeau, Lyne Villeneuve and Chantal Guillemette
      Drug Metabolism and Disposition April 2013, 41 (4) 694-697; DOI: https://doi.org/10.1124/dmd.112.050468

S

  1. Schuetz, Erin G.

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  2. Sensenhauser, Carlo

    1. You have access
      Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes
      Shannon Dallas, Souvik Chattopadhyay, Carlo Sensenhauser, Ameesha Batheja, Monica Singer and Jose Silva
      Drug Metabolism and Disposition April 2013, 41 (4) 689-693; DOI: https://doi.org/10.1124/dmd.112.048884
  3. Shibata, Sachio

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  4. Shin, Jae-Gook

    1. You have access
      Identification and Characterization of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor in Liver Samples of Koreans and Caucasians
      Eun-Jung Choi, Yin-Jin Jang, Eun-Young Cha, Jae-Gook Shin and Sang Seop Lee
      Drug Metabolism and Disposition April 2013, 41 (4) 888-896; DOI: https://doi.org/10.1124/dmd.112.049791
  5. Shou, Wilson

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
  6. Shyu, Wen Chyi

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  7. Silva, Jose

    1. You have access
      Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes
      Shannon Dallas, Souvik Chattopadhyay, Carlo Sensenhauser, Ameesha Batheja, Monica Singer and Jose Silva
      Drug Metabolism and Disposition April 2013, 41 (4) 689-693; DOI: https://doi.org/10.1124/dmd.112.048884
  8. Singer, Monica

    1. You have access
      Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes
      Shannon Dallas, Souvik Chattopadhyay, Carlo Sensenhauser, Ameesha Batheja, Monica Singer and Jose Silva
      Drug Metabolism and Disposition April 2013, 41 (4) 689-693; DOI: https://doi.org/10.1124/dmd.112.048884
  9. Skinner, Steven

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  10. Sloneker, Steven

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033
  11. Smith, Kyla M.

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  12. Solon, Eric

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033
  13. Sorrentino, Brian P.

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  14. Sridar, Chitra

    1. You have access
      The Inactivation of Human CYP2E1 by Phenethyl Isothiocyanate, a Naturally Occurring Chemopreventive Agent, and Its Oxidative Bioactivation
      Yasushi Yoshigae, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition April 2013, 41 (4) 858-869; DOI: https://doi.org/10.1124/dmd.112.050609
  15. Stanek, Johann

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  16. Strzemienski, Paul

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033
  17. Sugimoto, Hiroshi

    1. You have access
      Retrospective Analysis of P-Glycoprotein–Mediated Drug-Drug Interactions at the Blood-Brain Barrier in Humans
      Hiroshi Sugimoto, Hideki Hirabayashi, Nobuyuki Amano and Toshiya Moriwaki
      Drug Metabolism and Disposition April 2013, 41 (4) 683-688; DOI: https://doi.org/10.1124/dmd.112.049577
  18. Svanberg, Petter

    1. You have access
      Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor
      Pär Nordell, Petter Svanberg, James Bird and Ken Grime
      Drug Metabolism and Disposition April 2013, 41 (4) 836-843; DOI: https://doi.org/10.1124/dmd.112.050377

T

  1. Tagawa, Yoshihiko

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033
    2. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  2. Taghizadeh, Nazbeh

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  3. Tamai, Ikumi

    1. You have access
      Evaluation of Hepatic Disposition of Paroxetine Using Sandwich-Cultured Rat and Human Hepatocytes
      Norikazu Matsunaga, Ken-ichi Nunoya, Masahiro Okada, Mikio Ogawa and Ikumi Tamai
      Drug Metabolism and Disposition April 2013, 41 (4) 735-743; DOI: https://doi.org/10.1124/dmd.112.049817
  4. Thirumaran, Ranjit K.

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  5. Thompson, Charles D.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  6. Tohyama, Kimio

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  7. Tojo, Hideaki

    1. You have access
      Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
      Akifumi Kogame, Yoshihiko Tagawa, Sachio Shibata, Hideaki Tojo, Maki Miyamoto, Kimio Tohyama, Takahiro Kondo, Shimoga Prakash, Wen Chyi Shyu and Satoru Asahi
      Drug Metabolism and Disposition April 2013, 41 (4) 727-734; DOI: https://doi.org/10.1124/dmd.112.049650
  8. Tomer, Kenneth B.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429

U

  1. Unadkat, Jashvant D.

    1. You have access
      A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
      Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan, Nina Isoherranen and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2013, 41 (4) 801-813; DOI: https://doi.org/10.1124/dmd.112.050161
  2. Urade, Yoshihiro

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344

V

  1. VanWert, Adam L.

    1. You have access
      Organic Anion Transporter 3 Interacts Selectively with Lipophilic β-Lactam Antibiotics
      Aaron T. Wolman, Michael R. Gionfriddo, Gregory A. Heindel, Paran Mukhija, Sarah Witkowski, Ajay Bommareddy and Adam L. VanWert
      Drug Metabolism and Disposition April 2013, 41 (4) 791-800; DOI: https://doi.org/10.1124/dmd.112.049569
  2. Villeneuve, Lyne

    1. You have access
      The Relative Protein Abundance of UGT1A Alternative Splice Variants as a Key Determinant of Glucuronidation Activity In Vitro
      Mélanie Rouleau, Joannie Roberge, Sarah-Ann Falardeau, Lyne Villeneuve and Chantal Guillemette
      Drug Metabolism and Disposition April 2013, 41 (4) 694-697; DOI: https://doi.org/10.1124/dmd.112.050468
  3. Vogel, Peter

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344

W

  1. Wakefield, James

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  2. Wanek, Thomas

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  3. Wang, Lifei

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
    2. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
  4. Wang, Xiaoli

    1. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
  5. Westlin, William

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  6. White, Kerry F.

    1. You have access
      Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity
      Christopher C. Arico-Muendel, Bruce Belanger, Dennis Benjamin, Heather S. Blanchette, Teresa M. Caiazzo, Paolo A. Centrella, Jennifer DeLorey, Elisabeth G. Doyle, Ulrike Gradhand, Sarah T. Griffin, Susan Hill, Matthew T. Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani Prasad, Steven Skinner, Nazbeh Taghizadeh, Charles D. Thompson, James Wakefield, William Westlin and Kerry F. White
      Drug Metabolism and Disposition April 2013, 41 (4) 814-826; DOI: https://doi.org/10.1124/dmd.112.048355
  7. Williams, Eric T.

    1. You have access
      Reversible Inhibition of Human Carboxylesterases by Acyl Glucuronides
      Natalie R. Inoue, Adrian Hall, W. George Lai and Eric T. Williams
      Drug Metabolism and Disposition April 2013, 41 (4) 698-703; DOI: https://doi.org/10.1124/dmd.112.050252
  8. Williams, Suzanne

    1. You have access
      Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
      Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser and Susan Kadlubar
      Drug Metabolism and Disposition April 2013, 41 (4) 870-877; DOI: https://doi.org/10.1124/dmd.112.048157
  9. Wilson, Susan D.

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033
  10. Windhorst, Albert D.

    1. You have access
      Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
      Jens P. Bankstahl, Marion Bankstahl, Kerstin Römermann, Thomas Wanek, Johann Stanek, Albert D. Windhorst, Maren Fedrowitz, Thomas Erker, Markus Müller, Wolfgang Löscher, Oliver Langer and Claudia Kuntner
      Drug Metabolism and Disposition April 2013, 41 (4) 754-762; DOI: https://doi.org/10.1124/dmd.112.049148
  11. Witkowski, Sarah

    1. You have access
      Organic Anion Transporter 3 Interacts Selectively with Lipophilic β-Lactam Antibiotics
      Aaron T. Wolman, Michael R. Gionfriddo, Gregory A. Heindel, Paran Mukhija, Sarah Witkowski, Ajay Bommareddy and Adam L. VanWert
      Drug Metabolism and Disposition April 2013, 41 (4) 791-800; DOI: https://doi.org/10.1124/dmd.112.049569
  12. Wolman, Aaron T.

    1. You have access
      Organic Anion Transporter 3 Interacts Selectively with Lipophilic β-Lactam Antibiotics
      Aaron T. Wolman, Michael R. Gionfriddo, Gregory A. Heindel, Paran Mukhija, Sarah Witkowski, Ajay Bommareddy and Adam L. VanWert
      Drug Metabolism and Disposition April 2013, 41 (4) 791-800; DOI: https://doi.org/10.1124/dmd.112.049569
  13. Woodburn, Kathryn W.

    1. You have access
      Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration
      Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya and Yoshihiko Tagawa
      Drug Metabolism and Disposition April 2013, 41 (4) 774-784; DOI: https://doi.org/10.1124/dmd.112.048033

X

  1. Xia, Chunhua

    1. You have access
      Identification of the Active Components in Shenmai Injection that Differentially Affect Cyp3a4-Mediated 1′-Hydroxylation and 4-Hydroxylation of Midazolam
      Caiwen Zeng, Fang He, Chunhua Xia, Hong Zhang and Yuqing Xiong
      Drug Metabolism and Disposition April 2013, 41 (4) 785-790; DOI: https://doi.org/10.1124/dmd.112.048025
  2. Xiong, Yuqing

    1. You have access
      Identification of the Active Components in Shenmai Injection that Differentially Affect Cyp3a4-Mediated 1′-Hydroxylation and 4-Hydroxylation of Midazolam
      Caiwen Zeng, Fang He, Chunhua Xia, Hong Zhang and Yuqing Xiong
      Drug Metabolism and Disposition April 2013, 41 (4) 785-790; DOI: https://doi.org/10.1124/dmd.112.048025

Y

  1. Yao, Sylvia Y.M.

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  2. Yao-Borengasser, Aiwei

    1. You have access
      Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
      Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser and Susan Kadlubar
      Drug Metabolism and Disposition April 2013, 41 (4) 870-877; DOI: https://doi.org/10.1124/dmd.112.048157
  3. Yasuda, Kazuto

    1. You have access
      Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier
      Kazuto Yasuda, Cynthia Cline, Peter Vogel, Mihaela Onciu, Soghra Fatima, Brian P. Sorrentino, Ranjit K. Thirumaran, Sean Ekins, Yoshihiro Urade, Ko Fujimori and Erin G. Schuetz
      Drug Metabolism and Disposition April 2013, 41 (4) 923-931; DOI: https://doi.org/10.1124/dmd.112.050344
  4. Yoo, Byunggil

    1. You have access
      RNA-Sequencing Quantification of Hepatic Ontogeny and Tissue Distribution of mRNAs of Phase II Enzymes in Mice
      Hong Lu, Sumedha Gunewardena, Julia Y. Cui, Byunggil Yoo, Xiao-bo Zhong and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2013, 41 (4) 844-857; DOI: https://doi.org/10.1124/dmd.112.050211
  5. Yoshigae, Yasushi

    1. You have access
      The Inactivation of Human CYP2E1 by Phenethyl Isothiocyanate, a Naturally Occurring Chemopreventive Agent, and Its Oxidative Bioactivation
      Yasushi Yoshigae, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition April 2013, 41 (4) 858-869; DOI: https://doi.org/10.1124/dmd.112.050609
  6. Young, James D.

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858

Z

  1. Zamek-Gliszczynski, Maciej J.

    1. You have access
      Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
      Maciej J. Zamek-Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts, Palaniappan Kulanthaivel, Kimberley A. Jackson, Kay H. Chow, Denis J. McCann, Haitao Hu, Shelby Anderson, Nathan A. Furr, Robert J. Barbuch and Kenneth C. Cassidy
      Drug Metabolism and Disposition April 2013, 41 (4) 714-726; DOI: https://doi.org/10.1124/dmd.112.048488
  2. Zeldin, Darryl C.

    1. You have access
      Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
      Joan P. Graves, Matthew L. Edin, J. Alyce Bradbury, Artiom Gruzdev, Jennifer Cheng, Fred B. Lih, Tiwanda A. Masinde, Wei Qu, Natasha P. Clayton, James P. Morrison, Kenneth B. Tomer and Darryl C. Zeldin
      Drug Metabolism and Disposition April 2013, 41 (4) 763-773; DOI: https://doi.org/10.1124/dmd.112.049429
  3. Zeng, Caiwen

    1. You have access
      Identification of the Active Components in Shenmai Injection that Differentially Affect Cyp3a4-Mediated 1′-Hydroxylation and 4-Hydroxylation of Midazolam
      Caiwen Zeng, Fang He, Chunhua Xia, Hong Zhang and Yuqing Xiong
      Drug Metabolism and Disposition April 2013, 41 (4) 785-790; DOI: https://doi.org/10.1124/dmd.112.048025
  4. Zhang, Donglu

    1. You have access
      Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
      Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 827-835; DOI: https://doi.org/10.1124/dmd.112.050260
    2. You have access
      Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
      Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
      Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
  5. Zhang, Hong

    1. You have access
      Identification of the Active Components in Shenmai Injection that Differentially Affect Cyp3a4-Mediated 1′-Hydroxylation and 4-Hydroxylation of Midazolam
      Caiwen Zeng, Fang He, Chunhua Xia, Hong Zhang and Yuqing Xiong
      Drug Metabolism and Disposition April 2013, 41 (4) 785-790; DOI: https://doi.org/10.1124/dmd.112.048025
  6. Zhang, Jing

    1. You have access
      Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1
      Eve-Irene Lepist, Vijaya L. Damaraju, Jing Zhang, Wendy P. Gati, Sylvia Y.M. Yao, Kyla M. Smith, Edward Karpinski, James D. Young, Kwan H. Leung and Carol E. Cass
      Drug Metabolism and Disposition April 2013, 41 (4) 916-922; DOI: https://doi.org/10.1124/dmd.112.049858
  7. Zhao, Ping

    1. You have access
      A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
      Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan, Nina Isoherranen and Jashvant D. Unadkat
      Drug Metabolism and Disposition April 2013, 41 (4) 801-813; DOI: https://doi.org/10.1124/dmd.112.050161
  8. Zhong, Xiao-bo

    1. You have access
      RNA-Sequencing Quantification of Hepatic Ontogeny and Tissue Distribution of mRNAs of Phase II Enzymes in Mice
      Hong Lu, Sumedha Gunewardena, Julia Y. Cui, Byunggil Yoo, Xiao-bo Zhong and Curtis D. Klaassen
      Drug Metabolism and Disposition April 2013, 41 (4) 844-857; DOI: https://doi.org/10.1124/dmd.112.050211
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 41 (4)
Drug Metabolism and Disposition
Vol. 41, Issue 4
1 Apr 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics